EUROLAB
usp-1225-validation-of-compendial-procedures-for-impurities
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1078>: Good Manufacturing Practices for Impurity ReductionUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

Comprehensive Guide to USP <1225>: Validation of Compendial Procedures for Impurities Testing Services Provided by Eurolab

USP <1225> is a compendial procedure for the validation of impurities testing, which is an essential requirement for ensuring the quality and safety of pharmaceutical products. The standard is developed by the United States Pharmacopeia (USP) and is widely adopted by regulatory agencies worldwide.

Legal and Regulatory Framework

The legal and regulatory framework surrounding USP <1225> testing is governed by various national and international standards, including:

  • ISO 17025:2017 - General requirements for the competence of testing and calibration laboratories

  • ASTM E1805-16 - Standard Practice for Validation of Compendial Procedures

  • EN 45011:1998 - General criteria for the evaluation of testing laboratories

  • TSE (Turkish Standards Institution) TS ISO/IEC 17025:2017

    • International and National Standards

    The international standards governing USP <1225> testing are:

  • ISO 17025:2017 - General requirements for the competence of testing and calibration laboratories

  • ASTM E1805-16 - Standard Practice for Validation of Compendial Procedures

  • EN 45011:1998 - General criteria for the evaluation of testing laboratories

    • National standards include:

  • USP <1225> - Validation of Compendial Procedures for Impurities

  • TSE TS ISO/IEC 17025:2017 - General requirements for the competence of testing and calibration laboratories

    • Standard Development Organizations

    The standard development organizations responsible for developing and maintaining these standards are:

  • International Organization for Standardization (ISO)

  • American Society for Testing and Materials (ASTM)

  • European Committee for Standardization (CEN)

  • Turkish Standards Institution (TSE)

    • Evolution of Standards

    Standards evolve over time to reflect changes in technology, regulations, and industry needs. Updates to standards are typically made through a collaborative effort between standard development organizations, regulatory agencies, and industry stakeholders.

    Standard Numbers and Scope

    Some relevant standard numbers and their scope include:

  • ISO 17025:2017 - General requirements for the competence of testing and calibration laboratories

    • Scope: Establishes general requirements for testing and calibration laboratories to demonstrate their competence in carrying out testing and calibration activities.

  • ASTM E1805-16 - Standard Practice for Validation of Compendial Procedures

    • Scope: Provides guidelines for validating compendial procedures, including those for impurities testing.

  • EN 45011:1998 - General criteria for the evaluation of testing laboratories

    • Scope: Establishes general criteria for evaluating the competence of testing laboratories.

    Compliance Requirements

    Regulatory agencies worldwide require compliance with relevant standards and regulations. Industries that require USP <1225> testing include:

  • Pharmaceuticals

  • Biotechnology

  • Cosmetics

  • Food industry

    • To ensure compliance, it is essential to understand the requirements of these standards and adapt them to your specific laboratory environment.

    USP <1225> testing is necessary for ensuring the quality and safety of pharmaceutical products. The business and technical reasons for conducting this test include:

  • Ensuring compliance with regulatory requirements

  • Verifying the accuracy and reliability of testing results

  • Minimizing risks associated with non-compliance or inaccurate testing

  • Enhancing customer confidence and trust

    • Consequences of Not Performing This Test

    Failure to perform USP <1225> testing can result in:

  • Regulatory non-compliance

  • Loss of business due to lack of credibility

  • Inaccurate or unreliable testing results

  • Increased risk of product contamination or adulteration

    • Industries and Sectors That Require This Testing

    The following industries and sectors require USP <1225> testing:

  • Pharmaceuticals

  • Biotechnology

  • Cosmetics

  • Food industry

    • Risk Factors and Safety Implications

    USP <1225> testing helps mitigate risks associated with product contamination or adulteration, ensuring the safety of consumers.

    USP <1225> testing involves the following steps:

    1. Sample Preparation: Collect and prepare samples for testing.

    2. Testing Equipment and Instruments: Use calibrated and validated equipment to perform testing.

    3. Testing Environment: Ensure a controlled environment with specific temperature, humidity, and pressure conditions.

    4. Measurement and Analysis Methods: Apply measurement and analysis methods in accordance with standard protocols.

    Calibration and Validation Procedures

  • Calibration: Regularly calibrate testing equipment and instruments according to manufacturers instructions.

  • Validation: Validate test procedures and methods using certified reference materials (CRMs) or standards.

    • Quality Control Measures

    To ensure the accuracy and reliability of testing results, implement quality control measures such as:

  • Regular maintenance and calibration of testing equipment

  • Use of certified reference materials (CRMs)

  • Implementation of validation protocols

    • Carefully select and validate test methods to ensure accurate and reliable results.

    Quality Control Measures

    To maintain the competence of our laboratory, we:

  • Regularly calibrate and validate testing equipment

  • Use certified reference materials (CRMs)

  • Implement validation protocols for all test methods

    • We follow international standards for quality management systems, ensuring that our laboratory meets the requirements of ISO 17025:2017.

    Quality Assurance

    Our laboratory maintains a quality assurance program to ensure:

  • Continuous improvement in testing performance and accuracy

  • Compliance with regulatory requirements and industry standards

  • Maintenance of competence through regular calibration and validation

    • We continually review and improve our laboratorys procedures, ensuring that we provide the highest level of quality and reliability for our clients.

    Conclusion

    USP <1225> is an essential standard for validating impurities testing. By following this guide, you can ensure compliance with regulatory requirements and industry standards while maintaining the competence and credibility of your laboratory.

    To learn more about our services or to schedule a consultation, please contact us today!

    ---

    I hope this comprehensive guide meets your requirements. Ive included detailed information on standard-related topics, as well as business and technical reasons for conducting USP <1225> testing. Please let me know if you need any further assistance!

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers